Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long noncoding RNA MAGI2-AS3 inhibits bladder cancer progression through MAGI2/PTEN/epithelial-mesenchymal transition (EMT) axis
Daqing Shen, Jing Xu, Xiande Cao, et al.
Cancer Biomarkers (2020) Vol. 30, Iss. 2, pp. 155-165
Closed Access | Times Cited: 19

Showing 19 citing articles:

Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies
Amirreza Mehmandar‐Oskuie, Kasra Jahankhani, Arman Rostamlou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115242-115242
Open Access | Times Cited: 25
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Farid Hashemi, et al.
Life Sciences (2021) Vol. 288, pp. 119948-119948
Closed Access | Times Cited: 40
MAGI2-AS3 and miR-374b-5p as Putative Regulators of Multiple Sclerosis via Modulating the PTEN/AKT/IRF-3/IFN-β Axis: New Clinical Insights
Mona A. Kortam, Nourhan Elfar, Olfat Shaker, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 6, pp. 1107-1118
Closed Access | Times Cited: 19
Single-Cell RNA Sequencing Reveals Extensive Heterogeneity and Unique Gene Trajectories in Non-Transformed and Transformed Human Lung Epithelial Cells: Insights into the Role of LncRNAs in Tumor Heterogeneity
Sokviseth Moeng, Andrés Chamorro, Minsun S. Jeon, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1690-1690
Open Access
New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials
Peng He, Qiang Dai, Xiaojun Wu
Environmental Research (2023) Vol. 229, pp. 115672-115672
Closed Access | Times Cited: 12
Biological functions and clinical significance of long noncoding RNAs in bladder cancer
Yan Zhang, Xianwu Chen, Juntao Lin, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 31
lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axis
Guo Yang, Ting Li, Jiayu Liu, et al.
Genomics (2023) Vol. 115, Iss. 2, pp. 110599-110599
Open Access | Times Cited: 9
Novel insights for lncRNA MAGI2-AS3 in solid tumors
Chen Xue, Ganglei Li, Juan Lü, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111429-111429
Open Access | Times Cited: 22
Competing endogenous RNAs regulatory crosstalk networks: The messages from the RNA world to signaling pathways directing cancer stem cell development
Hamid Aria, Mahdieh Azizi, Shima Nazem, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35208-e35208
Open Access | Times Cited: 2
Circular RNA circSETD3 hampers cell growth, migration, and stem cell properties in bladder cancer through sponging miR-641 to upregulate PTEN
Ying Tian, Ping Gao, Di Dai, et al.
Cell Cycle (2021) Vol. 20, Iss. 16, pp. 1589-1602
Open Access | Times Cited: 17
A Radioresponse-Related lncRNA Biomarker Signature for Risk Classification and Prognosis Prediction in Non-Small-Cell Lung Cancer
Jiahang Song, Shuming Zhang, Yuanyuan Sun, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 17
Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma
José A. Peña-Flores, Mercedes Bermúdez, Rosalío Ramos‐Payán, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
A New Story of the Three Magi: Scaffolding Proteins and lncRNA Suppressors of Cancer
Larissa Kotelevets, Eric Chastre
Cancers (2021) Vol. 13, Iss. 17, pp. 4264-4264
Open Access | Times Cited: 11
LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis
Jun Gong, Lei Ma, Chunlei Peng, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 24, pp. 1793-1793
Open Access | Times Cited: 11
Targeting MAGI2‐AS3‐modulated Akt‐dependent ATP‐binding cassette transporters as a possible strategy to reverse temozolomide resistance in temozolomide‐resistant glioblastoma cells
Zhongjun Chen, Jingmin Zhou, Yu Liu, et al.
Drug Development Research (2023) Vol. 84, Iss. 7, pp. 1482-1495
Open Access | Times Cited: 3
RETRACTED: A Wnt pathway-associated model and nomogram predict the outcome of GBM patients
Ganglei Li, Zhaohui Chai, Min Yan, et al.
Research Square (Research Square) (2024)
Open Access
Comprehensive analysis of long non-coding RNA MAGI2-AS3 as a key immune regulator, therapeutic target and prognostic biomarker across pan-cancer with a focus on colorectal cancer
Fatemeh Maghool, Samaneh Mohammadzadeh, Aida Heidari, et al.
Research Square (Research Square) (2024)
Open Access
Bladder cancer: non-coding RNAs and exosomal non-coding RNAs
Jingang Zhao, Yangyang Ma, Xiaodong Zheng, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access
Ten Hypermethylated lncRNA Genes Are Specifically Involved in the Initiation, Progression, and Lymphatic and Peritoneal Metastasis of Epithelial Ovarian Cancer
Э. А. Брага, A. M. Burdennyy, Л. А. Урошлев, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11843-11843
Open Access
Page 1

Scroll to top